Association of peripheral blood leukocyte KIBRA methylation with gastric cancer risk: a case–control study

KIBRA was reported to be involved in various types of cancer and can be detected in blood. The purpose of this study was to investigate the relationship between the status of KIBRA methylation in peripheral blood leukocytes and gastric cancer (GC) risk. A case–control study was carried out to evaluate the association of blood cell‐derived KIBRA methylation with the risk of GC using methylation‐sensitive high‐resolution melting analysis. A total of 393 cases and 393 controls were detected, respectively. Compared with the subjects in the KIBRA negative methylation (NM) group, positive methylation (PM) subjects exhibited a 1.52‐fold (95% CI: 1.030–2.251, P = 0.035) increased risk for GC. Stratified analyses demonstrated that the significant association of KIBRA methylation with GC risk existed in the older group (≥ 60 years; OR(a )= 1.846, 95% CI: 1.037–3.287, P = 0.037) and Helicobacter pylori (H. pylori) positive subjects (OR(a )= 1.933, 95% CI: 1.103–3.386, P = 0.021). Statistically significant combination effects between the environmental factors and KIBRA methylation on the GC risk were observed except for storing food under refrigeration. KIBRA methylation derived from blood cells and combinations thereof with environmental factors may be associated with the risk of GC.